SCHLIEREN, Switzerland and SAN FRANCISCO, Oct. 3, 2019 /PRNewswire/ -- Akero Therapeutics and InSphero AG today announced that Akero has selected InSphero's 3D InSight™ Human Liver Disease Platform to ...
SCHLIEREN, ZURICH, SWITZERLAND, February 11, 2026 /EINPresswire.com/ — InSphero AG, the global market leader in 3D cell-based assays and organ-on-chip systems ...
ZURICH, Oct. 15, 2024 /PRNewswire/ -- InSphero, the global leader in 3D cell culture technology, and scientists from the U.S. Food and Drug Administration's (FDA) National Center for Toxicological ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results